Anounce Back to the GTRU 2022, the closing event of the DIM Thérapie Génique 28 November 2022 Anounce, News Crispr-Cas9 molecular scissors used for the first time in human to treat inherited blindness 19 March 2020 Anounce, News Two CAR T drugs, awarded the Prix Galien France 2019 in the “Innovative therapy medicine” category 13 January 2020 Anounce, News France Culture dédie une de ces émissions à la thérapie génique 19 December 2019 Anounce, News Gensight LUMEVOQ™, a gene therapy treatment will be used in Paris to treat blindness 12 December 2019 Anounce, News First CRISPR treatment shows promising results for 2 patients suffering from blood disorder 9 December 2019 Anounce, News Le DIM Thérapie Génique sensibilise le grand public à la thérapie génique 14 November 2019 Anounce, News Journées Européennes du Patrimoine 2019 28 August 2019 Anounce, News A major research project in gene therapy is financed thanks to the RHU call of projects 19 July 2019 Anounce, News Dr. Annarita Miccio team obtains an AFM Telethon grant for the sickle cell diseases project 11 June 2019 Anounce, News FDA approved a new gene therapy treatment in Spinal Muscular Atrophy 29 May 2019 Anounce, News Interview: Nick Leschly, CEO at Bluebird Bio 2 May 2019 Page 1 sur 212»
Anounce, News Crispr-Cas9 molecular scissors used for the first time in human to treat inherited blindness 19 March 2020 Anounce, News Two CAR T drugs, awarded the Prix Galien France 2019 in the “Innovative therapy medicine” category 13 January 2020 Anounce, News France Culture dédie une de ces émissions à la thérapie génique 19 December 2019 Anounce, News Gensight LUMEVOQ™, a gene therapy treatment will be used in Paris to treat blindness 12 December 2019 Anounce, News First CRISPR treatment shows promising results for 2 patients suffering from blood disorder 9 December 2019 Anounce, News Le DIM Thérapie Génique sensibilise le grand public à la thérapie génique 14 November 2019 Anounce, News Journées Européennes du Patrimoine 2019 28 August 2019 Anounce, News A major research project in gene therapy is financed thanks to the RHU call of projects 19 July 2019 Anounce, News Dr. Annarita Miccio team obtains an AFM Telethon grant for the sickle cell diseases project 11 June 2019 Anounce, News FDA approved a new gene therapy treatment in Spinal Muscular Atrophy 29 May 2019 Anounce, News Interview: Nick Leschly, CEO at Bluebird Bio 2 May 2019 Page 1 sur 212»
Anounce, News Two CAR T drugs, awarded the Prix Galien France 2019 in the “Innovative therapy medicine” category 13 January 2020 Anounce, News France Culture dédie une de ces émissions à la thérapie génique 19 December 2019 Anounce, News Gensight LUMEVOQ™, a gene therapy treatment will be used in Paris to treat blindness 12 December 2019 Anounce, News First CRISPR treatment shows promising results for 2 patients suffering from blood disorder 9 December 2019 Anounce, News Le DIM Thérapie Génique sensibilise le grand public à la thérapie génique 14 November 2019 Anounce, News Journées Européennes du Patrimoine 2019 28 August 2019 Anounce, News A major research project in gene therapy is financed thanks to the RHU call of projects 19 July 2019 Anounce, News Dr. Annarita Miccio team obtains an AFM Telethon grant for the sickle cell diseases project 11 June 2019 Anounce, News FDA approved a new gene therapy treatment in Spinal Muscular Atrophy 29 May 2019 Anounce, News Interview: Nick Leschly, CEO at Bluebird Bio 2 May 2019 Page 1 sur 212»
Anounce, News France Culture dédie une de ces émissions à la thérapie génique 19 December 2019 Anounce, News Gensight LUMEVOQ™, a gene therapy treatment will be used in Paris to treat blindness 12 December 2019 Anounce, News First CRISPR treatment shows promising results for 2 patients suffering from blood disorder 9 December 2019 Anounce, News Le DIM Thérapie Génique sensibilise le grand public à la thérapie génique 14 November 2019 Anounce, News Journées Européennes du Patrimoine 2019 28 August 2019 Anounce, News A major research project in gene therapy is financed thanks to the RHU call of projects 19 July 2019 Anounce, News Dr. Annarita Miccio team obtains an AFM Telethon grant for the sickle cell diseases project 11 June 2019 Anounce, News FDA approved a new gene therapy treatment in Spinal Muscular Atrophy 29 May 2019 Anounce, News Interview: Nick Leschly, CEO at Bluebird Bio 2 May 2019 Page 1 sur 212»
Anounce, News Gensight LUMEVOQ™, a gene therapy treatment will be used in Paris to treat blindness 12 December 2019 Anounce, News First CRISPR treatment shows promising results for 2 patients suffering from blood disorder 9 December 2019 Anounce, News Le DIM Thérapie Génique sensibilise le grand public à la thérapie génique 14 November 2019 Anounce, News Journées Européennes du Patrimoine 2019 28 August 2019 Anounce, News A major research project in gene therapy is financed thanks to the RHU call of projects 19 July 2019 Anounce, News Dr. Annarita Miccio team obtains an AFM Telethon grant for the sickle cell diseases project 11 June 2019 Anounce, News FDA approved a new gene therapy treatment in Spinal Muscular Atrophy 29 May 2019 Anounce, News Interview: Nick Leschly, CEO at Bluebird Bio 2 May 2019 Page 1 sur 212»
Anounce, News First CRISPR treatment shows promising results for 2 patients suffering from blood disorder 9 December 2019 Anounce, News Le DIM Thérapie Génique sensibilise le grand public à la thérapie génique 14 November 2019 Anounce, News Journées Européennes du Patrimoine 2019 28 August 2019 Anounce, News A major research project in gene therapy is financed thanks to the RHU call of projects 19 July 2019 Anounce, News Dr. Annarita Miccio team obtains an AFM Telethon grant for the sickle cell diseases project 11 June 2019 Anounce, News FDA approved a new gene therapy treatment in Spinal Muscular Atrophy 29 May 2019 Anounce, News Interview: Nick Leschly, CEO at Bluebird Bio 2 May 2019 Page 1 sur 212»
Anounce, News Le DIM Thérapie Génique sensibilise le grand public à la thérapie génique 14 November 2019 Anounce, News Journées Européennes du Patrimoine 2019 28 August 2019 Anounce, News A major research project in gene therapy is financed thanks to the RHU call of projects 19 July 2019 Anounce, News Dr. Annarita Miccio team obtains an AFM Telethon grant for the sickle cell diseases project 11 June 2019 Anounce, News FDA approved a new gene therapy treatment in Spinal Muscular Atrophy 29 May 2019 Anounce, News Interview: Nick Leschly, CEO at Bluebird Bio 2 May 2019 Page 1 sur 212»
Anounce, News Journées Européennes du Patrimoine 2019 28 August 2019 Anounce, News A major research project in gene therapy is financed thanks to the RHU call of projects 19 July 2019 Anounce, News Dr. Annarita Miccio team obtains an AFM Telethon grant for the sickle cell diseases project 11 June 2019 Anounce, News FDA approved a new gene therapy treatment in Spinal Muscular Atrophy 29 May 2019 Anounce, News Interview: Nick Leschly, CEO at Bluebird Bio 2 May 2019 Page 1 sur 212»
Anounce, News A major research project in gene therapy is financed thanks to the RHU call of projects 19 July 2019 Anounce, News Dr. Annarita Miccio team obtains an AFM Telethon grant for the sickle cell diseases project 11 June 2019 Anounce, News FDA approved a new gene therapy treatment in Spinal Muscular Atrophy 29 May 2019 Anounce, News Interview: Nick Leschly, CEO at Bluebird Bio 2 May 2019 Page 1 sur 212»
Anounce, News Dr. Annarita Miccio team obtains an AFM Telethon grant for the sickle cell diseases project 11 June 2019 Anounce, News FDA approved a new gene therapy treatment in Spinal Muscular Atrophy 29 May 2019 Anounce, News Interview: Nick Leschly, CEO at Bluebird Bio 2 May 2019 Page 1 sur 212»
Anounce, News FDA approved a new gene therapy treatment in Spinal Muscular Atrophy 29 May 2019 Anounce, News Interview: Nick Leschly, CEO at Bluebird Bio 2 May 2019 Page 1 sur 212»
